Latest Strategic Reset News

Chimeric Therapeutics reports encouraging clinical progress in its CAR-T and NK cell therapy trials, alongside FDA orphan drug designation and a strategic funding boost to propel development.

Altech Batteries has reported a significant technical milestone with its Silumina Anodes™ technology achieving 88.5% capacity retention after 500 cycles, alongside a $6 million capital raise and a strategic board renewal focused on commercialisation.

Chimeric Therapeutics has raised $8.4 million to fully fund its lead CHM CDH17 CAR-T Phase 1/2 trial through Phase 1, while initiating a strategic reset to sharpen focus and reduce costs.

Altech Batteries has abruptly ended its partnership with AMPower, shifting focus to its own advanced battery technologies as part of a strategic reset by its new board.

Treasury Wine Estates moderates its first-half fiscal 2026 outlook due to softer US and China markets, unveiling a major transformation program targeting $100 million in annual cost savings starting next year.

Following a critical ASIC Inquiry Interim Report, ASX has pledged a strategic reset including a $150 million capital charge and enhanced board independence to restore market confidence.

McPherson’s Limited has unveiled a sweeping two-year transformation, streamlining its brand portfolio and adopting a scalable third-party logistics model to drive growth and improve financial stability.

Frontier Digital Ventures is narrowing its focus to core classifieds, cutting loss-making units and revising FY25 earnings guidance to reflect a significant net loss. The company also reveals a potentially dilutive employee share plan in its Latin America subsidiary.

Fletcher Building has prepaid all US Private Placement notes, simplifying its capital structure and reducing interest costs, while extending key credit facilities to bolster liquidity.

Mach7 Technologies has inked a five-year subscription agreement with UnityPoint Health, marking the first commercial deployment of its new Flamingo Architecture and setting the stage for significant recurring revenue growth.

Altech Batteries has refreshed its board and launched a strategic reset aimed at accelerating the commercial rollout of its advanced CERENERGY and Silumina Anodes™ battery technologies.

Delorean Corporation marks a pivotal shift to build-own-operate bioenergy projects with the completion of its $53 million Yarra Valley Water facility and strong progress on its SA1 Salisbury project, backed by $51.5 million in financing and robust market demand.